✦ LIBER ✦

Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction

✍ Scribed by Renpei Kobatake; Tetsuya Sato; Yasukazu Fujiwara; Haruki Sunami; Ryo Yoshioka; Tetsuya Ikeda; Hironori Saito; Toru Ujihira

Publisher: Springer
Year: 2010
Tongue: English
Weight: 182 KB
Volume: 26
Category: Article
ISSN: 0910-8327
DOI: 10.1007/s00380-010-0065-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of slow/no-reflow phenomenon w

Treatment of slow/no-reflow phenomenon with intracoronary nitroprusside injection in primary coronary intervention for acute myocardial infarction

✍ Huang-Joe Wang; Ping-Hang Lo; Jen-Jyh Lin; Han Lee; Jui-Sung Hung 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 2 views

The Use of Intracoronary Sodium Nitropru

The Use of Intracoronary Sodium Nitroprusside to Treat No-Reflow after Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

✍ Milorad B. Tesic; Goran Stankovic; Vladan Vukcevic; Miodrag C. Ostojic 📂 Article 📅 2010 🏛 Urban and Vogel 🌐 German ⚖ 290 KB

Intracoronary adenosine administered dur

Intracoronary adenosine administered during percutaneous intervention in acute myocardial infarction and reduction in the incidence of “no reflow” phenomenon

✍ Abid R. Assali; Stefano Sdringola; Mohammad Ghani; Ali E. Denkats; Armando Yepes 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 49 KB 👁 2 views

Percutaneous intervention in acute myocardial infarction has been associated with a high incidence of "no reflow," ranging from 11% to 30%, with an increased risk of complications. The role of intracoronary adenosine for the prevention of this phenomenon has not been evaluated fully. We studied the